JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The isolated rabbit lung preparation is a gold standard tool in pulmonary research. This publication aims to describe the technique as developed for the study of physiological and pathological mechanisms involved in airway reactivity, lung preservation, and preclinical research in lung transplantation and pulmonary edema.

Abstract

The isolated lung perfusion system has been widely used in pulmonary research, contributing to elucidate the lungs' inner workings, both micro and macroscopically. This technique is useful in the characterization of pulmonary physiology and pathology by measuring metabolic activities and respiratory functions, including interactions between circulatory substances and the effects of inhaled or perfused substances, as in drug testing. While in vitro methods involve the slicing and culturing of tissues, the isolated ex vivo lung perfusion system allows to work with a complete functional organ making possible the study of a continuous physiological function while recreating ventilation and perfusion. However, it should be noted that the effects of the absence of central innervation and lymphatic drainage still have to be fully assessed. This protocol aims to describe the assembly of the isolated lung apparatus, followed by the surgical extraction and cannulation of lungs and heart from experimental lab animals, as well as to display the perfusion technique and signal processing of data. The average viability of the isolated lung ranges between 5-8 h; during this period, the pulmonary capillary permeability increases, causing edema and lung injury. The functionality of preserved pulmonary tissue is measured by the capillary filtration coefficient (Kfc), used to determine the extent of pulmonary edema through time.

Introduction

Brodie and Dixon first described the ex-vivo lung perfusion system in 1903 1. Since then, it has become a gold standard tool for studying the physiology, pharmacology, toxicology, and biochemistry of the lungs2,3. The technique offers a consistent and reproducible way to evaluate the viability of lung transplants, and to determine the effect of inflammatory mediators such as histamine, arachidonic acid metabolites, and substance P, among others, as well as their interactions during pulmonary phenomena such as bronchoconstriction, atelectasis, and pulmonary edema. The isolated lung system has been a key technique in unveiling the important role of the lungs in the elimination of biogenic amines from general circulation4,5. Additionally, the system has been used to evaluate the biochemistry of pulmonary surfactant6. Over the last few decades, the ex-vivo lung perfusion system has become an ideal platform for lung transplantation research7. In 2001 a team lead by Stig Steen described the first clinical application of the ex-vivo lung perfusion system by using it to recondition the lungs of a 19-year-old donor, who was initially rejected by transplantation centers due to its injuries. The left lung was harvested and perfused for 65 min; afterward, it was successfully transplanted into a 70-year-old man with COPD8. Further research into lung reconditioning using the ex-vivo perfusion led to developing the Toronto technique for extended lung perfusion to assess and treat injured donor lungs9,10. Clinically, the ex-vivo lung perfusion system has shown to be a safe strategy to increase donor pools by treating and reconditioning sub-standard donor lungs, presenting no significant difference in risks or outcomes against standard criteria donors10.

The main advantage of the isolated lung perfusion system is that the experimental parameters can be evaluated in a complete functional organ that preserves its physiological function under an artificial laboratory setup. Furthermore, it allows the measurement and manipulation of pulmonary mechanical ventilation to analyze the components of pulmonary physiology such as airway resistance, total vascular resistance, gas exchange, and edema formation, which to date cannot be measured precisely in vivo on lab animals2. Notably, the composition of the solution with which the lung is perfused can be fully controlled, enabling the addition of substances to evaluate their effects in real-time and sample collection from perfusion for further study11. Researchers working with the isolated lung system should bear in mind that mechanical ventilation causes decay of the pulmonary tissue shortening its useful time. This progressive fall in mechanical parameters can be significantly delayed by hyperinflating the lungs occasionally during the time of the experiment4. Still, the preparation cannot usually last more than eight hours. Another consideration for the ex-vivo lung perfusion system is the absence of central nervous regulation and lymphatic drainage. The effects of their absence are not yet fully understood and could potentially be a source of bias in certain experiments.

The isolated lung perfusion system technique can be performed in the rabbit model with a high degree of consistency and reproducibility. This work describes the technical and surgical procedures for the implementation of the ex-vivo isolated lung perfusion technique as developed for the rabbit model at Instituto Nacional de Enfermedades Respiratorias in Mexico City, intending to share the insights and provide a clear guide on key steps in the application of this experimental model.

Protocol

The isolated perfusion system in the rabbit model has been widely used in the Bronchial Hyperresponsiveness Laboratory at the Instituto Nacional de Enfermedades Respiratorias. The protocol includes New Zealand rabbits with an approximate weight of 2.5-3 kg. All animals were kept in standard vivarium conditions and ad libitum feeding in compliance with the official Mexican guidelines for laboratory animals (NOM 062-ZOO-1999) and under the Guide for the Care and Use of Laboratory Animals (8th edition, 2011). All the animal procedures and animal care methods presented in this protocol were previously approved by the Ethics Committee of the Instituto Nacional de Enfermedades Respiratorias.

NOTE: The preparation of the isolated lung perfusion system involves the deliberate death of an animal under anesthesia and via euthanasia.

1. Equipment and preparation of apparatus.

  1. Equipment arrangement:
    1. Set up an operating table with size according to the weight of the rabbit.
    2. Mount the cover of the artificial thorax on the steel column with the glass chamber underneath and the ventilator with a roller pump by the sides.
    3. Ensure that the cover is easily inclined to have the tracheal cannula in line with the trachea to allow a faster connection.
  2. Artificial thorax:
    NOTE: It is an essential part of the system. It consists of a water-jacketed glass chamber sealed by a special cover. The cover works as the organ holder with the connections to cannulate the trachea and vessels embedded in it.
    1. Set up a venturi jet operated by compressed air to generate the negative pressure inside the artificial thorax.
      NOTE: The ventilation control module (VCM) allows separate adjustments of inspiratory and end-expiratory pressures as well as respiration rate and the ratio of inspiratory duration to total cycle duration.
  3. Apparatus:
    1. Ensure that a normally working apparatus consists of a main steel column mounted on a base plate holding the artificial thorax, with the pneumotachometer and weight transducer located above it and behind the preheating coil with a bubble trap.
    2. Connect one differential pressure transducer to the pneumotachometer and another to the chamber pressure. Set a different couple of pressure transducers behind the thorax to measure perfusion and venous pressures.
    3. Connect the changeover stock below the oxygenator with a level electrode and the ventilation system beside the apparatus.

2. Surgical extraction of the cardiopulmonary block.

  1. Anesthesia:
    1. Use a combination of a sedative (xylazine) and a barbiturate (pentobarbital).
      NOTE: Different anesthetic cocktails can be used with no effect on experimental outcomes.
    2. First, sedate the healthy New Zealand rabbits with a single intramuscular injection of xylazine hydrochloride (3-5 mg/kg). Ensure that the rabbits remain calm and relaxed to allow further manipulation after a few minutes of the injection.
    3. Following sedation, use the marginal (lateral) ear veins as access to anesthetize the rabbits with an intravenous injection of pentobarbital sodium (28 mg/kg).
  2. Monitoring:
    1. To avoid insufficient anesthesia or excessive depression of cardiac and respiratory functions, monitor the following parameters. To assess the depth of anesthesia, perform a toe pinch test.
    2. Ensure that the mucous membrane is pink. Blue or gray shades indicate hypoxia.
    3. Ensure that the heart rate is between 120-135 beats/min, and that the body temperature does not drop below 36.5 °C.
  3. Animal placement:
    1. Shave the rabbit's torso and place the animal on the operating table in supine position. Place the ventilation system near the table, behind the rabbit's head, to permit connecting the cannulae quickly after tracheotomy to avoid tissular damage.
  4. Incision and tracheotomy:
    1. Dissect the skin with a ventral median line incision of 3-5 cm from the diaphragm up to the neck.
    2. With the operating scissors, cut the anterior 2/3 of the trachea between two cartilage rings to insert the tracheal cannula through the tracheal fibrous membrane.
    3. Insert a 5 mm (outer diameter; OD) tracheal cannula through the tracheal fibrous membrane and use a 4-0 silk suture to fix it carefully.
    4. Place either forceps or tweezers underneath the trachea to ensure the cannula did not bend against the trachea.
  5. Positive-pressure ventilation:
    1. As long as the lungs remain outside the artificial thorax, use a small species respiration pump to ventilate a positive pressure in order to avoid lung collapse during the surgery.
    2. Initiate ventilation through the tracheal cannula connected to the respiration pump quickly after tracheotomy and before the thorax is opened.
    3. Set the tidal volume at 10 mL/kg.
      NOTE: Depending on the experiment setup and artificial thorax model, provide positive-pressure ventilation by either the same ventilation pump used to provide negative-pressure or a different one, granting a quick re-cannulation.
  6. Thoracotomy and exsanguination:
    1. To access the thoracic cavity, use a scalpel or scissors to open the thorax wall and perform a medial sternotomy up to the upper third of the thorax.
    2. Hold the thorax halves open by two retractors. Several lung flaps usually surround the heart.
    3. Localize the superior and inferior vena cava and refer them with threads.
    4. Prior to the exsanguination of the animal, identify the right ventricle and inject 1000 UI/kg of heparin.
    5. Immediately after the injection, ligate the superior and inferior vena cava with the pre-looped thread and perform exsanguination.
  7. Heart-lung harvest:
    1. Harvest the cardiopulmonary block gently and quickly. Use direct digital dissection or spring scissors to separate the connective tissue so as to remove the lungs from the thorax.
    2. Dissect the vasculature in the area, as well as the esophagus.
    3. Cut through the manubrium sterni to extend the medial sternotomy towards the tracheal cannula, releasing the trachea on both sides from connecting tissue.
    4. Now, resect the trachea above the tracheal cannula. Gently pull up the cannula in a craniocaudal axis as the dorsal fixation of the trachea and lungs is resected.
  8. Cannulation:
    1. Lift the isolated lungs out of the thorax and carefully place them over a sterile gauze on a petri dish.
    2. To prevent atelectasis, ventilate the lungs using positive-pressure ventilation with positive end-expiratory pressure (PEEP) set at 2 cmH2O.
    3. Remove the ventricles by cutting them off the heart at the level of the atrioventricular groove.
    4. After opening the two ventricles, introduce the OD 4.6 mm pulmonary artery cannula for the rabbit with a basket through the pulmonary artery and introduce the OD 5.9 mm left atrium cannula for the rabbit with the basket through the mitral valve into the left atrium.
    5. Use a 4-0 silk suture in the pulmonary artery and left atrium to fix the cannulaes. Include the surrounding tissues in the ligatures of the pulmonary artery and left atrium to avoid the distension of these structures.
    6. Inject 250 mL of saline isotonic solution through the arterial cannulae to flush the remaining blood from the vascular bed.

3. Perfusion technique.

  1. Setup:
    1. Place the isolated lungs carefully into the lung chamber.
    2. Attach the trachea to the transductor on the cover of the chamber.
    3. Connect the cannulated vessels to the perfusion system.
    4. Close the chamber and secure it with the rotary lock.
      NOTE: The recirculating perfusion circuit consists of an open venous reservoir, a peristaltic pump, a heat exchanger, and a bubble trap.
    5. At this point, attach the chamber lid and switch over a stopcock to switch from positive to negative pressure ventilation. To check the negative pressure ventilation of the lungs and airtight closure of the chamber, inspect the respiratory excursion of the lung and chamber pressure on the pressure gauge.
    6. Perfuse the lungs with 200 mL of artificial blood-free perfusate (a Krebs-Ringer bicarbonate buffer containing 2.5% of bovine albumin).
    7. Start the perfusate flow at 3 mL/min/kg, then slowly step up the flow over a 5-min period to 5 mL/min/kg. Reach a flow of 8 mL/min/kg over the next 5 min and then after another 5-min period reach a maximum flux of 10 mL/min/kg. Take care of avoiding air from getting into the circuit.
      NOTE: Maintain the pH and the temperature of the perfusate within physiological ranges (pH 7.4-7.5; temperature, 37 °C-38 °C). To adjust the pH, add NaHCO3 (1N) or increase the flow of carbon dioxide. Alternatively, use HCl (0.1N) to acidify.
  2. Parameters:
    1. Check whether the predetermined perfusion and ventilation parameters are set as required.
    2. Ventilate the lungs with humidified air at a frequency of 30 bpm, a tidal volume of 10 mL/kg, and an end-expiratory pressure (Pe) of 2 cmH2O.
      NOTE: The pulmonary arterial pressure (0-20 mmHg) corresponds to the height of the liquid level in the oxygenator or reservoir in centimeters above the pulmonary trunk, while the pulmonary venous pressure corresponds to the height of the pressure equilibration chamber above the left atrium. Both values can be modified. Note that left atrium pressure is also 0-20 mmHg.
  3. Achieving zone 3 conditions:
    1. Use the two catheters connected to side ports of the cannulae secured in the pulmonary artery, left atrium, and pressure transducers to measure the arterial (Pa) and venous (Pv) pressures.
    2. Set the baseline pressures at the level of the lung hilum (Zero-reference).
    3. Conduct the experiments under zone 3 ventilation conditions. To achieve this, wait for 10-15 min to obtain an equilibrium characterized by an isogravimetric state.
    4. Ensure that the venous pressure is higher than the alveolar pressure (Palv) and the arterial pressure remains higher than both (Pa > Pv > Palv) for Zone 3 conditions to occur.
    5. Ensure that the lungs' weight remains constant and arterial and left atrial pressures are stable to achieve zone 3 conditions to open up a maximum number of pulmonary vessels and maintain the microvascular bed content during the experiment.
      NOTE: The measurement of Kfc as an indicator of pulmonary edema has no variation between a manual and an automatic perfusion system.
  4. Electronic control and signal processing: Ensure that the respiratory flow, weight changes, microvascular pressure, tidal volume, vascular resistance, among others, are registered on a multiple central electronics unit that integrates signals coming from the transducers and displays them on the evaluation system.

Results

The isolated lung perfusion system allows organ manipulation for biopsy, sample collection from perfusion, and real-time data collection of physiological parameters. The isolated system can be used to test many hypotheses involving different functions and lung phenomena, from metabolic and enzymatic activity to edema formation and preservation periods for lung transplants.

Figure 1 displays a diagram of the fully assembled isolated lung perfusion system along...

Discussion

This work displays a general view of the isolated lung perfusion system, an essential technique in pulmonary physiology research. The isolated lung perfusion system offers a great degree of versatility in its uses and allows the evaluation of several parameters relevant in the testing of a wide range of hypotheses15. An isolated lung system is a tool with worldwide presence that, in the last decade, has further established its relevance for organ-specific evaluations and also expanded its usefulne...

Disclosures

The authors declare no conflicts of interest.

Acknowledgements

The authors would like to thank Ph.D. Bettina Sommer Cervantes for her support in the writing of this manuscript, and Kitzia Elena Lara Safont for her support with the illustrations.

Materials

NameCompanyCatalog NumberComments
2-Stop Tygon E-Lab Tubing, 3.17 mm ID, 12/pack, Black/WhiteHugo Sachs Elektronik (HSE)73-1864
Adapter for Positive Pressure Ventilation on IPL-4Hugo Sachs Elektronik (HSE)73-4312
Adapter for Positive Pressure Ventilation on IPL-4Hugo Sachs Elektronik (HSE)73-4312
Alternative Pressure-Free Gas Supply for IPL-4: To supply the trachea with gas mixture different from room air during negative ventilationHugo Sachs Elektronik (HSE)73-4309
Base Unit for the Rabbit to Fetal Pig Isolated Perfused LungHugo Sachs Elektronik (HSE)73-4138
Bovine serum A2:D41albumin lyophilized powdersigma3912500 g
Calcium chloride, CaCl2·2H2O.JT Baker10035-04-8
Cryogenic vialsCorning4306592 mL
D-glucosa, C6H12O6.sigmaG5767
Differential Low Pressure Transducer DLP2.5, Range +- 2.5 cmH2O, HSE ConnectorHugo Sachs Elektronik (HSE)73-3882
Differential Pressure Transducer MPX, Range +- 100 cmH2O, HSE ConnectorHugo Sachs Elektronik (HSE)73-0064
Eppendorf tubes
Ethanol absolute HPLC gradeCaledon
Falcon tubes14 mL
Harvard Peristaltic Pump P-230 (Complete with Control Box and P-230 Motor Drive)Hugo Sachs Elektronik (HSE)70-7001
Heated Linear Pneumotachometer 0 to 10 L/min flow rangeHugo Sachs Elektronik (HSE)59-9349
Heater Controller for Single Pneumotachometer 230 VAC, 50 HzHugo Sachs Elektronik (HSE)59-9703
HeparinPISA5000 UI
HPLC Column (C18 100A 5U)Alltech98121213150 mm x 4.6 mm
Hydrophilic Syringe FilterMillexSLLGR04NL4 mm
IPL-4 Core System for Isolated Rabbit to Fetal Pig Lung, 230Hugo Sachs Elektronik (HSE)73-4296
IPL-4 Core System for Isolated Rabbit to Fetal Pig Lung, 230 VHugo Sachs Elektronik (HSE)73-4296
Jacketed Glass Reservoir for Buffer Solution, with Frit and Tubing, 6.0 LHugo Sachs Elektronik (HSE)73-0322
Lauda Thermostatic Circulator, Type E-103, 230 V/50 Hz, 3 L Bath Volume, Temperature Range 20 to 150°CHugo Sachs Elektronik (HSE)73-0125
Left Atrium Cannula for Rabbit with Basket, OD 5.9 mmHugo Sachs Elektronik (HSE)73-4162
Low Range Blood Pressure Transducer P75 for PLUGSYS ModuleHugo Sachs Elektronik (HSE)73-0020
Magnesium sulfate heptahydrate, MgSO4·7H2OJT Baker10034-99-8
Microcentrifuge TubeCorning430909
Negative Pressure Ventilation Control Option with Pressure Regulator for IPL-4Hugo Sachs Elektronik (HSE)73-4298
New Zeland rabbits
PISABENTAL (Pentobarbital sodium)PISAQ-7833-215
PLUGSYS Case, Type 603* 7Hugo Sachs Elektronik (HSE)73-0045
PLUGSYS TCM Time Counter ModuleHugo Sachs Elektronik (HSE)73-1750
PLUGSYS Transducer Amplifier Module (TAM-A)Hugo Sachs Elektronik (HSE)73-0065
PLUGSYS Transducer Amplifier Module (TAM-D)Hugo Sachs Elektronik (HSE)73-1793
PLUGSYS VCM-4R Ventilation Control Module with Pressure RegulatorHugo Sachs Elektronik (HSE)73-1755
Potassium chloride, KCl.JT Baker3040-01
Potassium dihydrogen phosphate, KH2PO4JT Baker7778-77-0
PROCIN (Xylacine clorhydrate)PISAQ-7833-099
Pulmonary Artery Cannula for Rabbit with Basket, OD 4.6 mmHugo Sachs Elektronik (HSE)73-4161
Scalpel knife
Serotonin 5-HT
Servo Controller for Perfusion (SCPHugo Sachs Elektronik (HSE)73-2806
Snap Cap Microcentrifuge TubeCostar36201.7 mL
Sodium bicarbonate, NaHCO3sigmaS6014
Sodium chloride, NaCl.sigmaS9888
Surgical gloves No. 7 1/2
Surgical gloves No. 8
Taygon tubesMasterflex
Tracheal Cannula for Rabbit, OD 5.0 mmHugo Sachs Elektronik (HSE)73-4163

References

  1. Dixon, W. E. Contributions to the physiology of the lungs: Part I. The bronchial muscles, their innervation, and the action of drugs upon them. The Journal of Physiology. 29 (2), 97-173 (1903).
  2. Nelson, K., et al. Animal models of ex vivo lung perfusion as a platform for transplantation research. World Journal of Experimental Medicine. 4 (2), 7-15 (2014).
  3. Roman, M. A., Nair, S., Tsui, S., Dunning, J., Parmar, J. S. Ex vivo lung perfusion: a comprehensive review of the development and exploration of future trends. Transplantation. 96 (6), 509-518 (2013).
  4. Delaunois, A., Gustin, P., Ansay, M. Multiple muscarinic receptor subtypes mediating pulmonary oedema in the rabbit. Pulmonary Pharmacology. 7 (3), 185-193 (1994).
  5. Delaunois, A., Gustin, P., Vargas, M., Ansay, M. Protective effect of various antagonists of inflammatory mediators against paraoxon-induced pulmonary edema in the rabbit. Toxicology and Applied Pharmacology. 132 (2), 343-345 (1995).
  6. Barr, H. A., Nicholas, T. E., Power, J. H. Control of alveolar surfactant in rats at rest and during prolonged hyperpnoea: pharmacological evidence for two tissue pools of surfactant. British Journal of Pharmacology. 93 (3), 473-482 (1988).
  7. Machuca, T. N., Cypel, M. Ex vivo lung perfusion. Journal of Thoracic Disease. 6 (8), 1054-1062 (2014).
  8. Steen, S., et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. The Annals of Thoracic Surgery. 83 (6), 2191-2194 (2007).
  9. Cypel, M., et al. Technique for prolonged normothermic ex vivo lung perfusion. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart and Lung Transplantation. 27 (12), 1319-1325 (2008).
  10. Cypel, M., et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. New England Journal of Medicine. 364 (15), 1431-1440 (2011).
  11. Kao, C. C., Parulekar, A. D. Is perfusate exchange during. Annals of Translational Medicine. 8 (3), 43 (2020).
  12. Alquicira-Mireles, J. . Participación de la serotonina en los cambios de permeabilidad vascular en la preservación pulmonar en conejo. , (2013).
  13. Arreola-Ramírez, J. L. . Papel de la liberación de acetilcolina y sustancia P en el deterioro de la función pulmonar en un modelo experimental de preservación pulmonar en conejo. , (2009).
  14. Isolated lung perfusion systems for small to large animal models. Harvard Apparatus. Hugo Sachs Elektronik (HSE) Available from: https://www.harvardapparatus.com/media/harvard/pdf/Isolated%20Lung%20Perfusion%20Systems%20Brochure.pdf (2021)
  15. Jiao, G. Evolving trend of EVLP: Advancements and emerging pathways. SN Comprehensive Clinical Medicine. 1 (4), 287-303 (2019).
  16. Mordant, P., et al. Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart and Lung Transplantation. 35 (10), 1245-1254 (2016).
  17. Cowan, P. J., Hawthorne, W. J., Nottle, M. B. Xenogeneic transplantation and tolerance in the era of CRISPR-Cas9. Current Opinion in Organ Transplantation. 24 (1), 5-11 (2019).
  18. Collaborators, G. C. R. D. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Respiratory Medicine. 8 (6), 585-596 (2020).
  19. Bravo-Reyna, C. C., Torres-Villalobos, G., Aguilar-Blas, N., Frías-Guillén, J., Guerra-Mora, J. R. Comparative study of capillary filtration coefficient (Kfc) determination by a manual and automatic perfusion system. Step by step technique review. Physiological Research. 68 (6), 901-908 (2019).
  20. Pereira, M. R., et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. American Journal of Transplantation. 20 (7), 1800-1808 (2020).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Isolated Lung Perfusion SystemPulmonary PhysiologyPulmonary PathologyMetabolic ActivitiesRespiratory FunctionAlveolar MacrophageEndothelial TissueSurgical ProcedureTracheal CannulaVentilation SystemTidal VolumeThoracotomyHeparin InjectionRabbit ModelPositive Pressure Ventilation

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved